BioNTech SE (BNTX) Income towards Parent Company (2018 - 2025)

BioNTech SE (BNTX) reported Income towards Parent Company of -$174.4 million for Q4 2025, down 147.59% on a YoY basis from $366.4 million in Q4 2024, and down 290.98% sequentially from $91.3 million in Q3 2025.

BioNTech SE (BNTX) Income towards Parent Company (2018 - 2025) Analysis & Trends

BioNTech SE (BNTX) has 8 years of Income towards Parent Company data on file, last reported at -$174.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 147.59% year-over-year to -$174.4 million; the trailing twelve-month figure through Dec 2025 stood at -$1.1 billion (down 41.52% YoY), and the FY2025 full-year result was -$1.1 billion, down 47.92% from the prior year.
  • Income towards Parent Company slipped to -$174.4 million in Q4 2025, from $91.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $7.2 billion in Q3 2021 to a low of -$865.6 million in Q2 2024.
  • A 5-year average of $1.7 billion and a median of $343.3 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 1512953662792.27% in 2021 and tumbled 147.59% in 2025, its largest moves.
  • Tracing BNTX's Income towards Parent Company over 5 years: stood at $3622.0 in 2021, then surged by 114544050.96% to $4.1 billion in 2022, then plunged by 77.48% to $934.5 million in 2023, then sank by 60.79% to $366.4 million in 2024, then plunged by 147.59% to -$174.4 million in 2025.
  • Business Quant data shows BNTX's Income towards Parent Company at -$174.4 million in Q4 2025, $91.3 million in Q3 2025, and -$474.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 62.43 Bn 62.43 Bn -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 BioNTech SE 22.06 Bn 4.75 Bn 668.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -174.37 Mn
Sep 30, 2025 91.30 Mn
Jun 30, 2025 -474.06 Mn
Mar 31, 2025 -499.65 Mn
Dec 31, 2024 366.42 Mn
Sep 30, 2024 131.02 Mn
Jun 30, 2024 -865.60 Mn
Mar 31, 2024 -378.60 Mn
Dec 31, 2023 934.45 Mn
Sep 30, 2023 320.26 Mn
Jun 30, 2023 -690.38 Mn
Mar 31, 2023 980.18 Mn
Dec 31, 2022 4.15 Bn
Sep 30, 2022 3.13 Bn
Jun 30, 2022 3.17 Bn
Mar 31, 2022 7.11 Bn
Dec 31, 2021 3,622.04
Sep 30, 2021 7.22 Bn
Jun 30, 2021 6.33 Bn
Mar 31, 2021 2.60 Bn